Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species Transcriptomic and Network Analyses

Background: Hepatocellular carcinoma (HCC) is considered the most common type of liver cancer and the fourth leading cause of cancer-related deaths in the world. Since the disease is usually diagnosed at advanced stages, it has poor prognosis. Therefore, reliable biomarkers are urgently needed for e...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Harazi, Olfat, Kaya, Ibrahim H., Al-Eid, Maha, Alfantoukh, Lina, Al Zahrani, Ali Saeed, Al Sebayel, Mohammed, Kaya, Namik, Colak, Dilek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511318/
https://www.ncbi.nlm.nih.gov/pubmed/34659334
http://dx.doi.org/10.3389/fgene.2021.710049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511318/
https://www.ncbi.nlm.nih.gov/pubmed/34659334
http://dx.doi.org/10.3389/fgene.2021.710049

Ejemplares similares